<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04624282</url>
  </required_header>
  <id_info>
    <org_study_id>I2020001797</org_study_id>
    <nct_id>NCT04624282</nct_id>
  </id_info>
  <brief_title>Metabonomics Study of Chronic Gastritis and Gastric Carcinoma</brief_title>
  <official_title>Metabonomics Study of Chronic Gastritis and Gastric Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The pathogenetic mechanisms of chronic gastritis and gastric carcinoma are different. Whether&#xD;
      metabonomics play a role in the development of chronic gastritis and gastric cancer is still&#xD;
      a question. So the investigators want to clarify this question by this subject.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project was an untargeted metabolomics study using liquid chromatography coupled with&#xD;
      mass spectrometry (LC-MS) in patients with chronic gastritis and gastric carcinoma. The&#xD;
      experimental procedures mainly include sample collection, metabolite extraction, LC-MS/MS&#xD;
      detection, data analysis, etc.The goal of this study is to identify and (relatively) quantify&#xD;
      as many metabolites in biological systems as possible, so as to reveal the overall metabolite&#xD;
      information to the maximum extent. Metabolomics aims to investigate the changes of&#xD;
      metabolites in gastric tissues in patients with chronic gastritis and gastric carcinoma, and&#xD;
      to study the biological processes in which these metabolites participate by screening the&#xD;
      different metabolites in the different groups, and to reveal the mechanism of life activities&#xD;
      in which they involved in.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Metabonomic difference in patients with chronic gastritis and gastric carcinoma</measure>
    <time_frame>six months</time_frame>
    <description>1.The different levels of metabolites in gastric tissues in patients with chronic gastritis and gastric carcinoma. 2. The common change model of metabolites in gastric carcionoma compared with chronic gastritis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association of different metabolic substances and disease results in chronic gastritis and gastric carcinoma</measure>
    <time_frame>six months</time_frame>
    <description>The researchers want to reveal the relationship between different metabolic sustances and disease result in patientswith chronic gastritis and gastric carcinoma.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Patients with chronic superficial gastritis</arm_group_label>
    <description>Patients with chronic superficial gastritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with chronic atrophic gastritis</arm_group_label>
    <description>Patients with chronic atrophic gastritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with gastric carcinoma</arm_group_label>
    <description>Patients with gastric carcinoma</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>different diseases</intervention_name>
    <description>Patients will be divided into three groups, including chronic superficial gastritis ,chronic atrophic gastritis and gastric carcinoma.</description>
    <arm_group_label>Patients with chronic atrophic gastritis</arm_group_label>
    <arm_group_label>Patients with chronic superficial gastritis</arm_group_label>
    <arm_group_label>Patients with gastric carcinoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We will enroll patients with chronic superficial gastritis, chronic atrophic gastritis or&#xD;
        gastric carcinoma.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic superficial gastritis and chronic atrophic gastritis&#xD;
&#xD;
          -  Patients with gastric carcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of surgery&#xD;
&#xD;
          -  Patients with severe heart disease,lung disease or kidney disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuehua Han, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>2nd Affiliated Hospital, School of Medicine, Zhejiang university, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuehua Han, Dr.</last_name>
    <phone>+86 13858126927</phone>
    <email>13858126927@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>2nd Affiliated Hospital, School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang University</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuehua Han, Docter</last_name>
      <phone>86-0571-87783563</phone>
      <email>13858126927@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 19, 2020</study_first_submitted>
  <study_first_submitted_qc>November 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2020</study_first_posted>
  <last_update_submitted>January 17, 2021</last_update_submitted>
  <last_update_submitted_qc>January 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</investigator_affiliation>
    <investigator_full_name>Hanyuehua</investigator_full_name>
    <investigator_title>Chief physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Gastritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

